Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 15849 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke.DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER, BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.

Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all thetrillions and trillions of neuronsthatDIEeach daybecause there areNOeffective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Monday, January 15, 2018

Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial

Abstract

What is known:
Herbal medicines have been used in the treatment of behavioural and
psychological symptoms of dementia but with variable response. Crocus sativus
(saffron) may inhibit the aggregation and deposition of amyloid β in
the human brain and may therefore be useful in Alzheimer’s disease (AD).Objective: The goal of this study was to assess the efficacy of saffron in the treatment of mild to moderate AD.Methods:
Forty-six patients with probable AD were screened for a 16-week,
double-blind study of parallel groups of patients with mild to moderate
AD. The psychometric measures, which included AD assessment
scale-cognitive subscale (ADAS-cog), and clinical dementia rating
scale-sums of boxes, were performed to monitor the global cognitive and
clinical profiles of the patients. Patients were randomly assigned to
receive capsule saffron 30 mg/day (15 mg twice per day) (Group A) or
capsule placebo (two capsules per day) for a 16-week study.Results: After 16 weeks, saffron produced a significantly better outcome on cognitive function than placebo (ADAS-cog: F = 4·12, d.f. = 1, P = 0·04; CDR: F = 4·12, d.f. = 1, P = 0·04). There were no significant differences in the two groups in terms of observed adverse events.What is new and conclusion:
This double-blind, placebo-controlled study suggests that at least in
the short-term, saffron is both safe and effective in mild to moderate
AD. Larger confirmatory randomized controlled trials are called for.

No comments:

Post a Comment

Total Pageviews

Top 25 stroke blog

email me

Ask Dean
Any local survivors close to East Lansing, drop me a note and we can have coffee sometime.
Questions or comments or would you like me to discuss something? I will try to answer, No medical diagnosis given or received. I am damned opinionated so don't expect fluff.

Copyright

Canoeing Moose

Just because my goal is to get back to canoeing and this moose is so ripped and cool looking. And he's even a solo paddler. But his right hand on the T-grip is wrong and the right arm should be extended.